• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Applied Food Sciences, Inc.

    Aiya America, Inc. (Aiya Matcha)

    KLK OLEO

    Ecuadorian Rainforest
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Applied Food Sciences, Inc.

    Aiya America, Inc. (Aiya Matcha)

    KLK OLEO

    Ecuadorian Rainforest
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Legal Standards for Substantiating Dietary Supplement Advertising Claims

    Courts have consistently struck down FTC efforts to impose a higher standard for competent and reliable scientific evidence.

    Legal Standards for Substantiating Dietary Supplement Advertising Claims
    Related CONTENT
    • Thorne Relaunches Gut Health Test with Microbiome Wipe
    • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    • Choline Alone May Improve Maternal DHA Status During Pregnancy
    • Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    By Todd Harrison, Venable01.05.18
    Emerging case law on claims substantiation has clearly rejected the Federal Trade Commission’s prior consent decrees with Iovate and Nestlé, which required the companies to have two supporting placebo-controlled clinical trials on a particular product, or substantially similar product, in order to substantiate marketing claims for dietary supplements.

    However, this standard was never the legal standard. Yet, the FTC, state attorneys general, and plaintiff class-action lawyers attempted to create the illusion that it was the law, rather than a negotiated settlement between FTC and the companies. So, what is today’s standard for claims substantiation? It is the same standard that has always applied: competent and reliable scientific evidence (CRSE), which never required drug-like clinical trials to support marketing claims. 

    More specifically, under the FTC guidance, “Dietary Supplements: An Advertising Guide for Industry” (FTC Guide), the relevant standard for “truthful and not misleading” claims for dietary supplements is the CRSE standard, which is defined as “tests, analyses, research, studies, or other evidence based on the expertise of professionals in the relevant area, that have been conducted and evaluated in an objective manner by persons qualified to do so, using procedures generally accepted in the profession to yield accurate and reliable results.” 1

    A ‘Flexible Standard’
    Importantly, the FTC Guide does not require randomized clinical trials of dietary supplements and notes that “competent and reliable scientific evidence” is a “flexible” standard; there is “no fixed formula for the number or type of studies required.” Further, the FTC Guide notes that one should look to “the totality of the evidence” and that “studies on the precise formula used in the advertised product are not required.”2 

    Indeed, numerous federal courts have held that the CRSE standard is a flexible standard that requires careful analysis of the entire body of science, and it is not limited to only double-blind, placebo-controlled clinical trials. For example, the Seventh Circuit explicitly held that “[n]othing in the Federal Trade Commission Act … requires placebo-controlled, double-blind studies … [p]lacebo-controlled double-blind testing is not a legal requirement for consumer products.”3

    Indeed, courts have expressly found that when analyzing competent and reliable scientific evidence for advertising claims, “the FTC Guidance makes clear that this standard is not the drug standard. Randomized clinical trials are not required.”2

    Thus, in U.S. v. Bayer, the court rejected the FTC’s argument that competent and reliable scientific evidence could be met only through “human clinical trials that 1) are randomized, placebo-controlled, and double-blind; 2) use the specific product for which the claims are made; 3) are performed in the population at which the claims are directed; and 4) use validated methods and appropriate statistical methods to assess ‘outcomes.’”

    Moreover, courts have specifically held that advertisers may support claims on a final product using testing of the products’ ingredients. For example, the Bayer court concluded that studies on the precise formula used in the advertised product were not required, and the court therefore found claims based on ingredient studies were properly substantiated.
    Other courts have held that claims for a supplement were legally supported by CRSE where the marketer used an ingredient study to support claims for a final product that included additional ingredients.4

    Time and again, U.S. federal courts have reiterated the fundamental principle that, when advertising dietary supplements, “placebo-controlled, double-blind testing is not a legal requirement for consumer products” and “something less may do.”1,5

    Courts Reject Higher Standard
    Despite the FTC’s efforts to impose a higher standard for CRSE, courts have consistently struck these attempts.

    In 2012, the federal court for the District of Utah rejected the FTC’s allegations that an advertiser did not possess competent and reliable scientific evidence for its weight loss claims, including claims that users of the product “can eat all they want and still lose weight,” that the product “causes substantial weight loss,” and “causes weight loss for virtually all users.” The court explicitly rejected the FTC’s argument that the advertiser could only use randomized, double-blind, placebo-controlled clinical studies, and found the advertiser provided a reasonable basis for its claims based on clinical studies, as well as expert evaluations of those studies, in conjunction with animal and in vitro testing.4

    In reaching this conclusion, the court explained that “[w]hile competent and reliable scientific evidence may consist of a single study under certain circumstances, [it] does not require that every aspect of an advertising claim be contained in one study. Nor does it preclude drawing inferences and correlations between different studies.” 

    Indeed, the Basic Research court held that a “study proffered by the FTC supporting a conclusion that disagrees with the supporting evidence proffered by [an advertiser] does not prove that [the advertiser] lacked a reasonable basis for the representation.” Applying this standard, the court concluded that the weight loss claims “are supported by competent and reliable scientific evidence.”4

    In 2015, another federal court in U.S. v. Bayer explicitly rejected the FTC’s attempt to broaden the definition of “competent and reliable scientific evidence.” There, the court held that studies on the precise formula used in the advertised product are not required, and it can be “appropriate to extrapolate from the research to the claimed effect,” even if there “are significant discrepancies between the research conditions and the real life use being promoted.”

    Accordingly, the Bayer court denied the FTC’s argument that supplement advertisers must possess double-blind, placebo-controlled clinical trials with results achieved at a statistically significant level before disseminating advertising claims for their products.

    In September of this year, a third federal court rejected the FTC’s attempt to heighten the standard required for substantiating dietary supplement advertising claims.6 In FTC v. Quincy Bioscience, the U.S. Southern District of New York dismissed a case where the FTC alleged that advertising claims for a memory-enhancing dietary supplement were misleading.

    In particular, the court rejected the FTC’s argument that claims were inappropriate because the advertiser’s clinical study did not yield a statistically significant improvement in the treatment group over placebo as a whole. Accordingly, the court held that “all that is shown is that there are possibilities that the study’s results do not support its conclusion,” and this alone does not suffice to support a case that an advertising claim is misleading.

    Assessing Relevant Science
    These cases demonstrate that dietary supplement health and safety claims do not only require placebo-controlled clinical study results on the finished product, and that something less may suffice. In this regard, the FTC has argued that a statistically significant outcome does not establish a product had a treatment effect. However, the opposite is also true; a product can have a meaningful and relevant treatment effect but not reach statistical significance.

    In essence, the CRSE is not a static standard that requires statistical significance. Rather, it simply requires an assessment of the relevant scientific information by relevant experts to evaluate whether the product achieves the claimed benefits, a standard which “is sufficiently flexible to ensure that consumers have access to information about emerging areas of science.”2

    To put it more simply, claim substantiation should be based on whether credible and properly qualified experts have a reasonable basis to conclude the claim is supported by the science, and such opinions cannot be defeated by the government or a private plaintiff by simply stating “our experts disagree.” If courts would simply adopt this common-sense position, we may finally see a downtick in questionable enforcement actions and plaintiff class-action lawsuits. 

    References
    1. Available at http://bit.ly/2BaNVCD
    2. U.S. v. Bayer Corp., No. 07-cv-01(JLL), 2015 WL 5822595, at *4 (D.N.J. Sept. 24, 2015) (citing the FTC Guide).
    3. FTC v. QT, Inc. 512 F.3d 858 (7th Cir. Jan. 3, 2008).
    4. Basic Research, LLC v. FTC, No. 2:09-cv-0779, 2014 WL 12596497 (D. Utah Nov. 25, 2014).
    5. Bayer Phillips colon Health Probiotics Sales Practices Litigation, No. 11-cv-03017, 2017 WL 1395483 (Apr. 18, 2017).
    6. FTC v. Quincy Bioscience Holding Co., Inc., No. 17-cv-124 (LLS), 2017 WL 4382312, at *1 (S.D.N.Y. Sept. 28, 2017).

    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • labeling
    • fda
    • Dietary Supplements
    • Weight Loss
    Related Knowledge Center
    • Regulations
    • Dietary Supplements
    Suggested For You
    Thorne Relaunches Gut Health Test with Microbiome Wipe Thorne Relaunches Gut Health Test with Microbiome Wipe
    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Choline Alone May Improve Maternal DHA Status During Pregnancy Choline Alone May Improve Maternal DHA Status During Pregnancy
    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    Nutraceuticals for Men: Muscle Health and Performance Nutrition Nutraceuticals for Men: Muscle Health and Performance Nutrition
    Guayusa for Gametime: Opportunities in Esports and Beyond Guayusa for Gametime: Opportunities in Esports and Beyond
    Indena’s Meriva Curcumin Supplement May Benefit Kidney Function Indena’s Meriva Curcumin Supplement May Benefit Kidney Function
    Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits Undenatured Type II Collagen Ingredient Backed by Study for Joint Health Benefits
    Curcumin Ingredient Curcugen Sees Positive Results in Safety Study Curcumin Ingredient Curcugen Sees Positive Results in Safety Study
    Bonafide Acquires Patented, Enhanced SAM-e Formulation Bonafide Acquires Patented, Enhanced SAM-e Formulation
    Probiotic Combination Evidenced to Have Colic, GI Health Benefits in Infants Probiotic Combination Evidenced to Have Colic, GI Health Benefits in Infants
    BGG World to Double Capacity of Astaxanthin Facility for Second Time in Two Years BGG World to Double Capacity of Astaxanthin Facility for Second Time in Two Years
    Quatrefolic Supplementation May Improve Pregnancy Potential Quatrefolic Supplementation May Improve Pregnancy Potential
    Digestive, Gut Health Solutions Offer Downstream Benefits Digestive, Gut Health Solutions Offer Downstream Benefits

    Related Content

    • Digestive Health | Testing
      Thorne Relaunches Gut Health Test with Microbiome Wipe

      Thorne Relaunches Gut Health Test with Microbiome Wipe

      This first-to-market approach to testing makes stool sampling for the personalized test more user-friendly.
      05.24.22

    • Breaking News | Regulations | Supplier News | World Markets
      Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada

      Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada

      CTX-II clinical model patent has been used in multiple clinical trials to show NEM eggshell membrane helps protect cartilage in exercising individuals.
      05.24.22

    • Breaking News | Dietary Supplements | Infant & Children's Health | Medical Nutrition | Research News | Vitamins | Women's Health
      Choline Alone May Improve Maternal DHA Status During Pregnancy

      Choline Alone May Improve Maternal DHA Status During Pregnancy

      Independently of additional DHA intake, choline supplementation resulted in higher DHA status in maternal and umbilical cord blood.
      05.19.22


    • Breaking News | Dietary Supplements | Herbs & Botanicals | Industry & Market News | Quality & Safety | Testing
      Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods

      Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods

      BAPP’s 13th LGD provides in-depth assessment of relevant, reliable, and fit-for-purpose methods to authenticate ginkgo leaf extracts.
      05.10.22

    • HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe

      Several botanicals and the clinical trials backing them will be featured.
      05.04.22

      Trending
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Coca-Cola To Phase Out Honest Tea Brand By Year’s End, Citing Supply Chain Challenges | Nutraceuticals World
      Breaking News
      • Thorne Relaunches Gut Health Test with Microbiome Wipe
      • Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      • GC Rieber Foundations Expand Philanthropic Efforts
      • Danone Celebrates 10th anniversary of Grant Program for Probiotics Research
      • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Hosts The Future of Coatings' Technology Innovation Day in Amsterdam
      Azelis Expands Presence in India with Acquisition of Chemo India and Unipharm Laboratories
      Teknos Publishes Sustainability Report
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Pediatric Medical Device Competition Reveals Five Finalists
      Medical Device Packaging Market to Reach $34B by 2027
      Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Mirum Pharmaceuticals Acquires San Diego-based Satiogen
      Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals
      Insmed Appoints Drayton Wise as Chief Commercial Officer
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      3 Amorepacific Employees Stole $2.3 Million
      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Happi

      Latest Breaking News From Happi

      Thayers Natural Remedies Celebrates 175 Years with Social Campaign
      Former Model Shirley Powell’s Indie Beauty Brand LaJeanell Comprises Gender Inclusive Skincare and Makeup
      L’Oréal's New UVMune 400 Sun Filtering Technology Protects Skin From Ultra-Long UVA Rays
      Ink World

      Latest Breaking News From Ink World

      Flint Group Flexible Packaging Europe Implements Further Price Increase
      Nazdar Launches 205 Series Inks for Roland TrueVIS SG2 and VG2 Series Printers
      Quad Adds Landa S10P Nanographic Printing Press
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Study Confirms Knee Shapes are Highly Individualized
      Stryker Launches EasyFuse Dynamic Compression for Foot & Ankle
      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      InnovationLab Acquires Flexible Printed Battery Technology from Evonik
      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login